印度造血细胞移植的现状
Hematopoietic cell transplantation landscape in India.
作者信息
Nair Velu, Yanamandra Uday, Nazneen P S
机构信息
Chief Consultant & Head (Hematology & BMT), Apollo Cancer Center, Gandhinagar, Gujarat, India.
Former Dean, Armed Forces Medical College, Pune & DGMS (Army), Delhi Cantt, India.
出版信息
Med J Armed Forces India. 2023 Nov-Dec;79(6):621-630. doi: 10.1016/j.mjafi.2023.09.002. Epub 2023 Sep 13.
Hematopoietic cell transplantation (HCT), commonly known as Bone marrow transplantation (BMT), is a medical procedure used to treat various conditions, including blood cancers, genetic disorders, and certain autoimmune diseases. The procedure involves replacing damaged or diseased bone marrow with healthy stem cells to promote the production of new, healthy blood cells. In India, HCT has been performed for several years in specialized medical centers. India has a growing healthcare infrastructure, and many hospitals are equipped to perform these procedures. Though there are studies on HCTs done at individual transplant centers in India, a comprehensive analysis of the current landscape of HCT in the country is lacking. HCT in India has seen major advances both in the quantity and quality of HCT centers. This review article has attempted to cover the gaps of HCT in India, including its status in the Armed Forces HCT centers.
造血细胞移植（HCT），通常称为骨髓移植（BMT），是一种用于治疗各种病症的医疗程序，包括血癌、遗传疾病和某些自身免疫性疾病。该程序涉及用健康的干细胞替代受损或患病的骨髓，以促进新的健康血细胞的生成。在印度，造血细胞移植已在专业医疗中心开展了数年。印度的医疗保健基础设施不断发展，许多医院都具备进行这些程序的能力。尽管印度有个别移植中心开展造血细胞移植的相关研究，但该国目前造血细胞移植现状的全面分析尚付阙如。印度的造血细胞移植在移植中心的数量和质量方面均取得了重大进展。这篇综述文章试图填补印度造血细胞移植方面的空白，包括其在武装部队造血细胞移植中心的状况。
Zotero 插件